###begin article-title 0
###xml 34 37 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP</italic>
###xml 41 42 41 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</italic>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
Monocyte chemoattractant protein (MCP)-1 -2518 A/G SNP in Chinese Han patients with VKH syndrome
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
###xml 102 107 102 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 233 238 233 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
Vogt-Koyanagi-Harada (VKH) syndrome is an autoimmune disease. The monocyte chemoattractant protein-1 (MCP-1) gene has been implicated in the pathogenesis of certain autoimmune diseases. The aim of this study was to examine whether a MCP-1 polymorphism was associated with VKH syndrome.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
A case-control analysis was performed using genomic DNA samples from 307 VKH patients and 319 age-, sex-, and ethnically-matched healthy controls. The MCP-1 polymorphism at the -2518 A/G locus was genotyped using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) assay.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 281 286 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 243 251 <span type="species:ncbi:9606">patients</span>
The distribution of genotypic frequency of the MCP-1 -2518 A/G polymorphism in all subjects did not deviate from Hardy-Weinberg equilibrium (HWE; p>0.05). Allelic and genotypic frequency analysis revealed no significant difference between VKH patients and healthy controls for the MCP-1 -2518 A/G polymorphism (p>0.05). No significant differences were found according to gender and neither was found according to extraocular findings including neck stiffness, tinnitus, alopecia, poliosis, dysacusia, scalp hypersensitivity, and vitiligo.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 113 118 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 75 83 <span type="species:ncbi:9606">patients</span>
The result suggests that the susceptibility to VKH syndrome in Chinese Han patients may be not influenced by the MCP-1 -2518 A/G polymorphism.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 393 394 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 395 396 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 742 743 742 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 846 847 846 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 879 882 879 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 891 894 891 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 895 898 895 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DR4</italic>
###xml 903 912 903 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRw53</italic>
###xml 1026 1027 1026 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 1028 1029 1028 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 1228 1235 1228 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR4</italic>
###xml 1240 1249 1240 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRw53</italic>
###xml 1352 1355 1352 1355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 854 859 <span type="species:ncbi:9606">human</span>
###xml 956 964 <span type="species:ncbi:9606">patients</span>
Vogt-Koyanagi-Harada (VKH) syndrome is a multisystem disorder mainly affecting pigmented tissues in the eye, auditory, integumentary, and central nervous systems. The clinical features of VKH syndrome include bilateral granulomatous panuveitis frequently associated with extraocular findings including pleocytosis in the cerebrospinal fluid (CSF), dysacusis, alopecia, poliosis, and vitiligo [1-3]. Although the etiology and pathogenesis of VKH syndrome remain unclear, numerous studies have suggested that this syndrome is considered to be a cell-mediated autoimmune disease directed against melanocytes. Epidemiological studies show that VKH syndrome is more prevalent in certain racial and ethnic groups, particularly in pigmented groups [3] such as Asian and Latin-American populations and displays an adventive familial aggregation pattern [4]. Two human leukocyte antigen (HLA) genes, HLA-DR4 and HLA-DRw53, have been shown to be associated with VKH patients in various ethnic groups including the Chinese and Japanese [5-7]. These evidences suggest that immune-associated genetic factors may play a crucial role in the pathogenesis of VKH syndrome. However, the previously reported genetic risks for VKH syndrome such as HLA-DR4 and HLA-DRw53 account for only a small portion of the overall estimated risk for this syndrome, suggesting that non-HLA genes may confer a substantial proportion of genetic susceptibility to this syndrome. Therefore, studies on the disease association with genes involved in the immune response may highlight the genetic susceptibility to VKH syndrome.
###end p 10
###begin p 11
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 212 217 212 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 315 320 315 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 393 394 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 519 524 519 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 623 628 623 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 757 762 757 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 383 391 <span type="species:ncbi:9606">patients</span>
MCP-1 is a potent chemokine released by lymphocyte, monocytes, mast cells, and eosinophils during inflammation and also produced by ocular cells such as the retinal pigment epithelial cell cultured in vitro [8]. MCP-1 has been implicated in the recruitment of leukocytes into the site of inflammation. The elevated MCP-1 concentration in the aqueous humor of active anterior uveitis patients [9] and ocular fluids and tissues during ocular inflammation [9-13] combined with the recent reports showing an association of MCP-1 -2518 A/G polymorphism with uveitis [14-16] and multiple autoimmune diseases [17-19] suggest that MCP-1 may be involved in the pathogenesis of VKH syndrome. The present study was therefore designed to examine the association of the MCP-1 -2518 A/G polymorphism with VKH syndrome using a case-control association study.
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
Subjects
###end title 13
###begin p 14
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 178 189 <span type="species:ncbi:9606">participant</span>
###xml 198 209 <span type="species:ncbi:9606">participant</span>
###xml 307 315 <span type="species:ncbi:9606">patients</span>
###xml 616 624 <span type="species:ncbi:9606">patients</span>
This study was approved by the ethics committees of our hospitals and adhered to the tenets of the Declaration of Helsinki. Additionally, informed consent was obtained from each participant or each participant's guardian. After giving informed consent, blood samples were collected from 307 Chinese Han VKH patients and 319 age- and sex-matched, unrelated, healthy Chinese Han controls, which were recruited from Zhongshan Ophthalmic Center, Sun Yat-sen University (Guangzhou, P.R. China) and the First Affiliated Hospital, Chongqing Medical University (Chongqing, P.R. China) from April 2005 to March 2009. All VKH patients were diagnosed according to the revised criteria for VKH syndrome [20].
###end p 14
###begin title 15
DNA extraction
###end title 15
###begin p 16
###xml 80 88 <span type="species:ncbi:9606">patients</span>
Genomic DNA was prepared from peripheral blood mononuclear cells (PBMCs) of VKH patients and healthy controls using the QIAamp DNA Mini Blood Kit (Qiagen, Hilden, Germany) according to manufacturer's instructions. DNA samples were collected in a 1.5 ml Eppendorf tube and stored at -20 degreesC until use.
###end p 16
###begin title 17
Genotyping
###end title 17
###begin p 18
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP</italic>
###xml 23 24 23 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</italic>
Genotyping for the MCP-1 polymorphism (-2518A/G,  in  database) was performed using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). The forward primer, 5'-CCG CAT TCA ATT TCC CTT TAT-3', and reverse primer, 5'-TTC CAA AGC TGC CTC CTC A-3', were designed using primer premier 5.0 software (Premier Biosoft International, Palo Alto, CA). PCR reactions were performed under the following conditions: 10 min at 94 degreesC followed by 35 cycles at 95 degreesC for 45 s, 55 degreesC for 45 s, 72 degreesC for 45 s, and then for 3 min at 72 degreesC. The PCR products were incubated with PvuII at 37 degreesC (New England Biolabs Inc., Ontario, Canada) for at least 3 h and separated on 2% agarose gels. Ten percent of the PCR samples were directly sequenced to confirm the polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) results (Invitrogen Biotechnology Co., Shanghai, P.R. China).
###end p 18
###begin title 19
Statistical analysis
###end title 19
###begin p 20
###xml 154 155 152 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 241 242 237 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Statistical analysis was performed with the SPSS version 12.0 for Windows (SPSS Inc., Chicago, IL). Hardy-Weinberg Equilibrium (HWE) was tested by the chi2 test. We evaluated the frequency of genotypes and alleles in this study using the chi2 test. All statistical tests were two-sided, and statistical significance was taken when p<0.05.
###end p 20
###begin title 21
Results
###end title 21
###begin p 22
###xml 83 90 83 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 195 202 191 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 25 33 <span type="species:ncbi:9606">patients</span>
###xml 112 120 <span type="species:ncbi:9606">patients</span>
###xml 280 288 <span type="species:ncbi:9606">patients</span>
Clinical findings of VKH patients and characteristics of controls are presented in Table 1. The mean age of VKH patients was 34.3+/-10.3 years and that of healthy controls was 34.7+/-11.6 years (Table 1). There was no significant difference in the distribution of age between VKH patients and controls (p>0.05).
###end p 22
###begin title 23
###xml 21 29 <span type="species:ncbi:9606">patients</span>
Clinical findings of patients with VKH syndrome.
###end title 23
###begin p 24
###xml 51 59 <span type="species:ncbi:9606">patients</span>
This table summarizes the clinical findings of VKH patients.
###end p 24
###begin p 25
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 28 36 <span type="species:ncbi:9606">patients</span>
Three hundred and seven VKH patients and 319 healthy controls were genotyped for the MCP-1 -2518 A/G polymorphism. The result of genotyping was matched with that of direct sequencing for 10% of the samples. The distribution of genotypic frequency of this single nucleotide polymorphism (SNP) in all subjects did not show a significant deviation from Hardy-Weinberg equilibrium (HWE; p>0.05).
###end p 25
###begin p 26
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 104 111 104 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 190 195 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 271 276 271 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 482 487 482 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
The distributions of genotypic and allelic frequencies of the MCP-1 -2518 A/G polymorphism are shown in Table 2. No genetic association was demonstrated between the -2518A/G polymorphism of MCP-1 and VKH syndrome in an allele and genotype analysis, although the roles of MCP-1 in the immune diseases suggest its possible involvement in the development of VKH syndrome. In addition, our results did not indicate a significant difference when allelic and genotypic frequencies of the MCP-1 -2518 A/G polymorphism were analyzed according to gender and any one of extraocular findings including neck stiffness, tinnitus, alopecia, poliosis, dysacusia, scalp hypersensitivity, and vitiligo.
###end p 26
###begin title 27
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 66 74 <span type="species:ncbi:9606">Patients</span>
Frequencies of alleles and genotypes of MCP-1 polymorphism in VKH Patients and controls.
###end title 27
###begin p 28
###xml 92 100 <span type="species:ncbi:9606">patients</span>
###xml 207 215 <span type="species:ncbi:9606">patients</span>
The genotypic and allelic frequencies of MCP-1 -2518 A/G polymorphism were compared between patients and controls. No significant differences of the genotypic and allelic frequencies were found betweeen VKH patients and controls.
###end p 28
###begin title 29
Discussion
###end title 29
###begin p 30
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 189 194 189 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
The present study was to investigate the association of the MCP-1 polymorphism with VKH syndrome in the Chinese Han population. The results showed that there was no association between the MCP-1 polymorphism and VKH syndrome. The stratification analysis according to gender or extraocular findings did not show any association.
###end p 30
###begin p 31
###xml 343 349 343 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 380 385 380 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD1</italic>
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 510 513 510 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TYR</italic>
###xml 515 520 515 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TYRP1</italic>
###xml 526 529 526 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DCT</italic>
###xml 655 660 651 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 582 590 <span type="species:ncbi:9606">patients</span>
###xml 719 727 <span type="species:ncbi:9606">patients</span>
###xml 960 968 <span type="species:ncbi:9606">patients</span>
###xml 1448 1456 <span type="species:ncbi:9606">patients</span>
VKH syndrome is a multifactorial autoimmune disease that may result from interactions between susceptibility genes and environmental factors. Several studies have been performed to investigate the genetic risk for VKH syndrome. Recently, we reported two susceptible genes to VKH syndrome including cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) and programmed cell death 1 (PDCD1) in the Chinese population [21,22]. Horie and coworkers [23,24] showed a lack of association of the tyrosinase gene family (TYR, TYRP1, and DCT) and interferon-gamma with VKH syndrome in Japanese patients. In this study, we tested whether the -2518 A/G polymorphism of MCP-1, a crucial chemokine, was associated with Chinese Han VKH patients. As a case-control association study may be influenced by various factors including population composition and stratification, the present study drew up the following attempts to ensure the analysis results. First, the controls and patients were strictly matched according to the place where they were born to exclude the possible influence of stratification of the population. Individuals with any autoimmune disease and ocular inflammation were excluded from the controls by careful inquiry of history and, if necessary, by relevant examinations. Second, we restricted our study population to Chinese Han descent to minimize confounding by ethnic variation. Third, the number of donors enrolled in this study (307 VKH patients and 319 age-, sex-, ethnically-matched healthy controls) was large enough to avoid a bias of the results. Finally, direct sequencing for 10% of the samples was performed to validate the result of genotyping.
###end p 31
###begin p 32
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 701 706 701 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 957 962 957 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 1044 1046 1044 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 1245 1247 1245 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 1248 1250 1248 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 1251 1253 1251 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 1300 1305 1300 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 542 550 <span type="species:ncbi:9606">patients</span>
Several studies have been focused on the association of the MCP-1 -2518 A/G polymorphism with certain autoimmune diseases [15,25,26]. The investigated polymorphism, which is located in the promoter region of MCP-1, has been shown to affect the transcriptional activation of this gene [19]. Therefore, this polymorphism is considered a good candidate in the genetic predisposition to autoimmune diseases. Thus, we focused our study on the association of this polymorphism with VKH syndrome. Unexpectedly, no association was found in these VKH patients. As VKH syndrome is a multisystem disorder characterized by ocular and various extraocular findings, we further performed an association study of the MCP-1 polymorphism with these extraocular findings. Similarly, we did not find any association of this polymorphism with any one of these clinical findings. This result is consistent with the recent reports, which demonstrated a lack of association of the MCP-1 -2518 A/G polymorphism with multiple sclerosis (MS) and ulcerative colitis (UC) [27]. Contrary to our observation, this polymorphism was found to be significantly associated with rheumatic arthritis (RA), systemic lupus erythematosus (SLE), and juvenile rheumatoid arthritis (JRA) [25,28,29]. Taken together, these data suggest that the MCP-1 -2518 A/G polymorphism may play a role in certain but not all autoimmune diseases.
###end p 32
###begin p 33
###xml 355 360 355 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 554 559 554 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 608 613 608 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 655 660 655 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 697 705 <span type="species:ncbi:9606">patients</span>
Likewise with other candidate gene studies, several possible limitations exist in our study. A complex multigenic disease involves the interaction of various genetic and environmental factors. Therefore, it is unlikely that any single gene has an exclusive effect on the development of VKH syndrome. The present study only examined the association of the MCP-1 polymorphism with VKH syndrome but did not refer to the association study of the other susceptible genes. Furthermore, the tested polymorphism in this study is only one of the polymorphisms of MCP-1. It is necessary to examine all the tag SNPs of MCP-1 to understand the precise association of MCP-1 with VKH syndrome. In addition, the patients enrolled in this study were recruited from Chinese Han individuals, and so the results presented here need to be confirmed using different ethnic populations.
###end p 33
###begin p 34
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
In summary, the present study suggests that there was no association between the MCP-1 -2518 A/G polymorphism and VKH syndrome. This result remained in stratification analysis according to the gender and various clinical findings.
###end p 34
###begin title 35
Acknowledgments
###end title 35
###begin p 36
This work was supported by Key Project of Natural Science Foundation (30630064), National Supporting Project of P.R. China, Key Project of Health Bureau of Chongqing (2008-1-15), Key Project of Natural Science Foundation of Chongqing (CSTC, 2009BA5037), and Project of Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003). The authors would also like to thank all donors enrolled in the present study.
###end p 36
###begin title 37
References
###end title 37
###begin article-title 38
Vogt-Koyanagi-Harada syndrome.
###end article-title 38
###begin article-title 39
Echographic features of the Vogt-Koyanagi-Harada syndrome.
###end article-title 39
###begin article-title 40
###xml 69 77 <span type="species:ncbi:9606">patients</span>
Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients.
###end article-title 40
###begin article-title 41
Simultaneous onset of Vogt-Koyanagi-Harada syndrome in monozygotic twins.
###end article-title 41
###begin article-title 42
Association of HLA antigens with Vogt-Koyanagi-Harada syndrome in a Han Chinese population.
###end article-title 42
###begin article-title 43
###xml 10 15 <span type="species:ncbi:9606">human</span>
Profiling human leukocyte antigens in Vogt-Koyanagi-Harada syndrome.
###end article-title 43
###begin article-title 44
HLA class II genes in Vogt-Koyanagi-Harada disease.
###end article-title 44
###begin article-title 45
###xml 129 134 <span type="species:ncbi:9606">human</span>
Analysis of the secretion pattern of monocyte chemotactic protein-1 (MCP-1) and transforming growth factor-beta 2 (TGF-beta2) by human retinal pigment epithelial cells.
###end article-title 45
###begin article-title 46
Chemokines in acute anterior uveitis.
###end article-title 46
###begin article-title 47
###xml 89 94 <span type="species:ncbi:9606">human</span>
IL-4 potentiates IL-1beta- and TNF-alpha-stimulated IL-8 and MCP-1 protein production in human retinal pigment epithelial cells.
###end article-title 47
###begin article-title 48
Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis.
###end article-title 48
###begin article-title 49
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
###end article-title 49
###begin article-title 50
###xml 16 21 <span type="species:ncbi:9606">human</span>
Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses.
###end article-title 50
###begin article-title 51
Role of the CCL2/MCP-1 -2518A>G gene polymorphism in HLA-B27 associated uveitis.
###end article-title 51
###begin article-title 52
Polymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitis.
###end article-title 52
###begin article-title 53
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Chemokine gene polymorphisms associate with gender in patients with uveitis.
###end article-title 53
###begin article-title 54
Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity.
###end article-title 54
###begin article-title 55
The -2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis.
###end article-title 55
###begin article-title 56
A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression.
###end article-title 56
###begin article-title 57
Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature.
###end article-title 57
###begin article-title 58
Association of the CTLA-4 gene with Vogt-Koyanagi-Harada syndrome.
###end article-title 58
###begin article-title 59
###xml 74 82 <span type="species:ncbi:9606">patients</span>
PDCD1 genes may protect against extraocular manifestations in Chinese Han patients with Vogt-Koyanagi-Harada syndrome.
###end article-title 59
###begin article-title 60
###xml 68 76 <span type="species:ncbi:9606">patients</span>
Tyrosinase gene family and Vogt-Koyanagi-Harada disease in Japanese patients.
###end article-title 60
###begin article-title 61
Polymorphism of IFN-gamma gene and Vogt-Koyanagi-Harada disease.
###end article-title 61
###begin article-title 62
###xml 50 58 <span type="species:ncbi:9606">patients</span>
MCP-1, RANTES, and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus.
###end article-title 62
###begin article-title 63
###xml 39 47 <span type="species:ncbi:9606">patients</span>
MCP-1 promoter polymorphism in Spanish patients with rheumatoid arthritis.
###end article-title 63
###begin article-title 64
The combination of polymorphisms within MCP-1 and IL-1beta associated with ulcerative colitis.
###end article-title 64
###begin article-title 65
###xml 100 108 <span type="species:ncbi:9606">patients</span>
Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Turkish population and in Turkish patients with juvenile rheumatoid arthritis.
###end article-title 65
###begin article-title 66
The correlation between monocyte chemoattractant protein-1 and the arthritis of systemic lupus erythematosus among Chinese.
###end article-title 66

